At Sage Road, we’re dedicated to producing industry-leading research into the structural and cyclical themes that will define returns across asset classes, regions, and sectors. At a time of rampant short-termism, longer-term thinking is an even more vital investment edge. From my time at 13D Research to my tenure leading investment communications for Wellington Management, I’ve always struggled to find comprehensive, unbiased thinking on the biggest trends influencing investment outcomes. I founded Sage Road to fill that gap—to get beyond the day-to-day noise, challenge consensus thinking, and connect-the-dots on the key investment themes many may recognize, but few take the time to fully understand.
— Trevor Noren, Founder
Sage Road in the news
-
AI leader Anthropic reveals explosive growth, steep losses — and lots of risks
Opens in a new window. -
Anthropic says its AI models could manipulate, blackmail and harm humans
Opens in a new window. -
Trevor Noren on the $2.3 Trillion Hole at the Center of the AI Trade
Opens in a new window. -
W1M Podcast: Why Invest?
Opens in a new window. -
Trevor Noren – Building Sage Road Research and Seeing the Future
Opens in a new window.
Our Latest
GLOBAL ELECTRICITY UNDERSUPPLY
The globe faces accelerating electricity demand against persistently constrained supply. This will challenge AI buildout expectations. It is also a tailwind for companies neglected by the AI trade. How do investors leverage the electrification megatrend to mitigate risk and generate alpha in this moment of increasingly fragile AI sentiment?
THE AI TRADE
Throughout this year, the market has routinely sent messages of concern about the AI trade. We have high conviction concerns about AI's enterprise adoption, unit economics, and overextension risk will only intensify moving forward, dragging on the performance of AI stakeholders. How should investors position today to mitigate the risk of an AI sentiment rupture tomorrow?
THE MEDICAL INNOVATION INFLECTION
Exploring how AI is poised to supercharge the already-accelerating pace of medical innovation across biomedical science, patient care, and health systems, and why this return-defining megatrend remains overlooked amid the market's narrow fixation on AI's builders.
THE PRIVATE CREDIT RECKONING
Looking past the retail redemptions and news-cycle fear mongering to understand the private credit vulnerabilities built up over the past decade and the contagion potential of those vulnerabilities.